Cardiopulmonary Exercise Testing in the Age of New Heart Failure Therapies: Still a Powerful Tool?

Background: New therapies with prognostic benefits have been recently introduced in heart failure with reduced ejection fraction (HFrEF) management. The aim of this study was to evaluate the prognostic power of current listing criteria for heart transplantation (HT) in an HFrEF cohort submitted to c...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia Brás, Pedro, Gonçalves, António Valentim, Reis, João Ferreira, Moreira, Rita Ilhão, Pereira-da-Silva, Tiago, Rio, Pedro, Timóteo, Ana Teresa, Silva, Sofia, Soares, Rui M., Ferreira, Rui Cruz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452308/
https://www.ncbi.nlm.nih.gov/pubmed/37626705
http://dx.doi.org/10.3390/biomedicines11082208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452308/
https://www.ncbi.nlm.nih.gov/pubmed/37626705
http://dx.doi.org/10.3390/biomedicines11082208

Ejemplares similares